{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo%3A0.9%25+sodium+chloride&page=34", "query": { "intervention": "Placebo:0.9% sodium chloride", "page": 34 }, "page_size": 10 }, "pagination": { "page": 34, "page_size": 10, "total_count": 1586, "total_pages": 159, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo%3A0.9%25+sodium+chloride&page=35&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo%3A0.9%25+sodium+chloride&page=33&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-17T10:43:46.821Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03446456", "title": "Vasopressin and Pain Perception in the Brain", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Acute Pain" ], "interventions": [ { "name": "Arginine vasopressin", "type": "DRUG" }, { "name": "Saline", "type": "OTHER" }, { "name": "Observational learning", "type": "BEHAVIORAL" }, { "name": "fMRI data aquisition", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER", "BEHAVIORAL" ], "sponsor": "University of Maryland, Baltimore", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 56, "start_date": "2018-09-17", "completion_date": "2026-12-31", "has_results": true, "last_update_posted_date": "2026-07-09", "last_synced_at": "2026-10-17T10:43:46.821Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03446456" }, { "nct_id": "NCT05780541", "title": "PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "PF-07304814", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Remdesivir", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 58, "start_date": "2021-09-15", "completion_date": "2023-07-14", "has_results": true, "last_update_posted_date": "2024-02-09", "last_synced_at": "2026-10-17T10:43:46.821Z", "location_count": 31, "location_summary": "Chula Vista, California • Los Angeles, California • Mather, California + 23 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mather", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05780541" }, { "nct_id": "NCT02623829", "title": "Botulinum Toxin is a Potential Prophylactic Therapy for Minimizing Post-excisional Scarring (Allergan Botox Scar Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Post-operative Excessive Scarring" ], "interventions": [ { "name": "Botulinum Toxin", "type": "DRUG" }, { "name": "Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 42, "start_date": "2015-12-01", "completion_date": "2019-03-01", "has_results": true, "last_update_posted_date": "2020-12-08", "last_synced_at": "2026-10-17T10:43:46.821Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02623829" }, { "nct_id": "NCT05772156", "title": "Prophylactic Methylergonovine for Twin Cesarean", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Twin; Complicating Pregnancy", "Postpartum Hemorrhage" ], "interventions": [ { "name": "Methylergonovine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "65 Years", "sex": "FEMALE", "summary": "Up to 65 Years · Female only" }, "enrollment_count": 66, "start_date": "2023-03-07", "completion_date": "2024-03-11", "has_results": true, "last_update_posted_date": "2025-06-13", "last_synced_at": "2026-10-17T10:43:46.821Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05772156" }, { "nct_id": "NCT00317642", "title": "A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Myelogenous Leukemia" ], "interventions": [ { "name": "clofarabine (IV formulation)", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "cytarabine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genzyme, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "ALL", "summary": "55 Years and older" }, "enrollment_count": 326, "start_date": "2006-08", "completion_date": "2012-01", "has_results": true, "last_update_posted_date": "2014-04-14", "last_synced_at": "2026-10-17T10:43:46.821Z", "location_count": 41, "location_summary": "Scottsdale, Arizona • Tucson, Arizona • Little Rock, Arkansas + 34 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00317642" }, { "nct_id": "NCT02570503", "title": "Postoperative Pain Control After Periarticular Injection During Total Knee Arthroplasty", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Osteoarthritis, Knee" ], "interventions": [ { "name": "Ropivacaine", "type": "DRUG" }, { "name": "Ketorolac", "type": "DRUG" }, { "name": "Clonidine", "type": "DRUG" }, { "name": "Epinephrine", "type": "DRUG" }, { "name": "0.9% sodium chloride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Virginia Commonwealth University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 64, "start_date": "2015-10", "completion_date": "2021-02-11", "has_results": true, "last_update_posted_date": "2022-03-04", "last_synced_at": "2026-10-17T10:43:46.821Z", "location_count": 1, "location_summary": "Richmond, Virginia", "locations": [ { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02570503" }, { "nct_id": "NCT03313037", "title": "Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 60 Through 64 Years of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pneumococcal Infections" ], "interventions": [ { "name": "Multivalent", "type": "BIOLOGICAL" }, { "name": "Prevnar 13", "type": "BIOLOGICAL" }, { "name": "PPSV23", "type": "BIOLOGICAL" }, { "name": "Saline", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "60 Years to 64 Years" }, "enrollment_count": 444, "start_date": "2017-10-10", "completion_date": "2018-12-10", "has_results": true, "last_update_posted_date": "2019-12-26", "last_synced_at": "2026-10-17T10:43:46.821Z", "location_count": 14, "location_summary": "Anaheim, California • Coral Gables, Florida • DeLand, Florida + 11 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "DeLand", "state": "Florida" }, { "city": "South Miami", "state": "Florida" }, { "city": "Stockbridge", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03313037" }, { "nct_id": "NCT05683457", "title": "A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cytomegalovirus Infection" ], "interventions": [ { "name": "mRNA-1647", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "ModernaTX, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 84, "start_date": "2023-04-05", "completion_date": "2027-03-06", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-10-17T10:43:46.821Z", "location_count": 3, "location_summary": "Boston, Massachusetts • St Louis, Missouri • Seattle, Washington", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT05683457" }, { "nct_id": "NCT02270619", "title": "Sleep Health, Inflammation, and Emotion Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Depression" ], "interventions": [ { "name": "Endotoxin", "type": "BIOLOGICAL" }, { "name": "Partial sleep deprivation", "type": "BEHAVIORAL" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Uninterrupted sleep", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "BEHAVIORAL", "OTHER" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": "80 Years", "sex": "FEMALE", "summary": "60 Years to 80 Years · Female only" }, "enrollment_count": 95, "start_date": "2014-10", "completion_date": "2021-01", "has_results": false, "last_update_posted_date": "2021-02-18", "last_synced_at": "2026-10-17T10:43:46.821Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02270619" }, { "nct_id": "NCT02770807", "title": "Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Nervous System Disease", "Genetic Syndrome" ], "interventions": [ { "name": "EryDex Low dose DSP", "type": "DRUG" }, { "name": "EryDex High dose DSP", "type": "DRUG" }, { "name": "Pooled Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Quince Therapeutics S.p.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": null, "sex": "ALL", "summary": "6 Years and older" }, "enrollment_count": 176, "start_date": "2017-03-02", "completion_date": "2021-05-13", "has_results": true, "last_update_posted_date": "2024-05-10", "last_synced_at": "2026-10-17T10:43:46.821Z", "location_count": 4, "location_summary": "Los Angeles, California • Baltimore, Maryland • Cincinnati, Ohio + 1 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02770807" } ] }